Use of oral montelukast in the treatment of asthma

Compr Ther. 2001 Summer;27(2):148-55. doi: 10.1007/s12019-996-0010-9.

Abstract

Montelukast, a new leukotriene modifier, has several benefits in the treatment of asthma in adults and children including improved relief of asthma symptoms, rapid onset, a safety profile comparable with placebo, and oral, once-daily dosing means excellent adherence.

Publication types

  • Review

MeSH terms

  • Acetates / administration & dosage*
  • Administration, Oral
  • Adult
  • Anti-Asthmatic Agents / administration & dosage*
  • Asthma / drug therapy*
  • Bronchoconstriction
  • Child
  • Clinical Trials as Topic
  • Cyclopropanes
  • Drug Interactions
  • Exercise
  • Humans
  • Inflammation Mediators / physiology
  • Quinolines / administration & dosage*
  • Sulfides

Substances

  • Acetates
  • Anti-Asthmatic Agents
  • Cyclopropanes
  • Inflammation Mediators
  • Quinolines
  • Sulfides
  • montelukast